XML 53 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Segment information (Tables)
 6 Months Ended
Jun. 30, 2020
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
Three Months Ended June 30,Six Months Ended June 30,
In millions2020201920202019
Net sales
Performance Materials$84.4  $123.1  $205.5  $232.2  
Performance Chemicals186.2  229.7  353.3  397.4  
Total net sales (1)
$270.6  $352.8  $558.8  $629.6  
Segment EBITDA (2)
Performance Materials$23.3  $49.3  $84.5  $100.5  
Performance Chemicals43.9  59.0  74.9  91.3  
Total segment EBITDA (2)
$67.2  $108.3  $159.4  $191.8  
Interest expense, net(10.0) (13.1) (20.9) (24.2) 
(Provision) benefit for income taxes(5.2) (15.9) (15.1) (15.9) 
Depreciation and amortization - Performance Materials(7.3) (5.8) (14.5) (11.6) 
Depreciation and amortization - Performance Chemicals(16.8) (15.6) (33.9) (28.3) 
Restructuring and other income (charges), net (3)
(7.3) (0.3) (7.8) (0.3) 
Acquisition and other-related costs (4)
(0.4) (0.8) (1.7) (32.0) 
Net income (loss) $20.2  $56.8  $65.5  $79.5  
_______________
(1) Relates to external customers only, all intersegment sales and related profit have been eliminated in consolidation.
(2) Segment EBITDA is the primary measure used by our chief operating decision maker to evaluate the performance of and allocate resources among our operating segments. Segment EBITDA is defined as segment revenue less segment operating expenses (segment operating expenses consist of costs of sales, selling, general and administrative expenses, other (income) expense, net, excluding depreciation and amortization). We have excluded the following items from segment EBITDA: interest expense, net, associated with corporate debt facilities, income taxes, depreciation, amortization, restructuring and other (income) charges, net, acquisition and other-related costs, pension and postretirement settlement and curtailment (income) charges.
(3) Income (charges) for all periods presented relate to restructuring activity and costs associated with the business transformation initiative. For the three and six months ended June 30, 2020, charges of $2.7 million and $2.9 million relate to the Performance Material segment, respectively, and charges of $4.6 million and $4.9 million related the Performance Chemicals segment. For the three and six months ended June 30, 2019, all charges relate to the Performance Chemicals segment. For more detail on the charges incurred see Note 14 within these Condensed Consolidated Financial Statements.
(4) Charges associated with the acquisition and integration of the Caprolactone Business. For more detail on the charges incurred see Note 4 within these Condensed Consolidated Financial Statements.